Lotus Pharmaceutical Co Ltd
TWSE:1795

Watchlist Manager
Lotus Pharmaceutical Co Ltd Logo
Lotus Pharmaceutical Co Ltd
TWSE:1795
Watchlist
Price: 282 TWD 0.18%
Market Cap: 74.8B TWD
Have any thoughts about
Lotus Pharmaceutical Co Ltd?
Write Note

Lotus Pharmaceutical Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Lotus Pharmaceutical Co Ltd
Accounts Receivables Peer Comparison

Comparables:
Y
3705
4746
1789
S
4119
1720

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Lotus Pharmaceutical Co Ltd
TWSE:1795
Accounts Receivables
NT$6.1B
CAGR 3-Years
15%
CAGR 5-Years
27%
CAGR 10-Years
20%
Y
YungShin Global Holding Corp
TWSE:3705
Accounts Receivables
NT$1.5B
CAGR 3-Years
1%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Formosa Laboratories Inc
TWSE:4746
Accounts Receivables
NT$1.2B
CAGR 3-Years
19%
CAGR 5-Years
8%
CAGR 10-Years
4%
ScinoPharm Taiwan Ltd
TWSE:1789
Accounts Receivables
NT$478.6m
CAGR 3-Years
10%
CAGR 5-Years
2%
CAGR 10-Years
-5%
S
SCI Pharmtech Inc
TWSE:4119
Accounts Receivables
NT$368.8m
CAGR 3-Years
39%
CAGR 5-Years
-4%
CAGR 10-Years
7%
Standard Chem & Pharm Co Ltd
TWSE:1720
Accounts Receivables
NT$1.1B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
8%

See Also

What is Lotus Pharmaceutical Co Ltd's Accounts Receivables?
Accounts Receivables
6.1B TWD

Based on the financial report for Jun 30, 2024, Lotus Pharmaceutical Co Ltd's Accounts Receivables amounts to 6.1B TWD.

What is Lotus Pharmaceutical Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
20%

Over the last year, the Accounts Receivables growth was 0%. The average annual Accounts Receivables growth rates for Lotus Pharmaceutical Co Ltd have been 15% over the past three years , 27% over the past five years , and 20% over the past ten years .

Back to Top